6 ‘rare and severe’ blood clot cases, all in women, out of 6.8 million doses: US pauses Johnson & Johnson COVID-19 vaccine to review the evidence

Credit: Anadolu Agency
Credit: Anadolu Agency

The US Centers for Disease Control and Prevention and the US Food and Drug Administration are recommending that the United States pause the use of Johnson & Johnson’s Covid-19 vaccine over six reported US cases of a “rare and severe” type of blood clot.

The six reported cases were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States.

All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination, according to a joint statement on [April 13] from Dr. Anne Schuchat, principal deputy director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

ADVERTISEMENT

Johnson & Johnson issued a statement on [April 13] noting that the company has decided to “proactively delay the rollout” of its vaccine in Europe.

“We have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public,” the statement said in part.

For people who have received the Johnson & Johnson shot, those who have developed severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination should contact their health care provider, according to the statement.

Read the original post

ADVERTISEMENT
ADVERTISEMENT
Related article:  Despite anti-vax fears, vaccines are safe
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend